位置:首页 > 蛋白库 > WHIB2_MYCSM
WHIB2_MYCSM
ID   WHIB2_MYCSM             Reviewed;         129 AA.
AC   Q9S426;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 54.
DE   RecName: Full=Transcriptional regulator WhiB2;
GN   Name=whmD; Synonyms=whiB2;
OS   Mycolicibacterium smegmatis (Mycobacterium smegmatis).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycolicibacterium.
OX   NCBI_TaxID=1772;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=mc(2)6 1-2c;
RX   PubMed=10880571; DOI=10.1073/pnas.140225297;
RA   Gomez J.E., Bishai W.R.;
RT   "whmD is an essential mycobacterial gene required for proper septation and
RT   cell division.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:8554-8559(2000).
RN   [2]
RP   SUBCELLULAR LOCATION, INDUCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=mc(2)6 1-2c;
RX   PubMed=16946268; DOI=10.1099/mic.0.28911-0;
RA   Raghunand T.R., Bishai W.R.;
RT   "Mycobacterium smegmatis whmD and its homologue Mycobacterium tuberculosis
RT   whiB2 are functionally equivalent.";
RL   Microbiology 152:2735-2747(2006).
RN   [3]
RP   FUNCTION, COFACTOR, SUBUNIT, AND MUTAGENESIS OF CYS-67; ASP-71; CYS-90;
RP   CYS-93; CYS-99; GLY-111 AND LEU-116.
RC   STRAIN=mc(2)6 1-2c;
RX   PubMed=16980499; DOI=10.1128/jb.00384-06;
RA   Raghunand T.R., Bishai W.R.;
RT   "Mapping essential domains of Mycobacterium smegmatis WhmD: insights into
RT   WhiB structure and function.";
RL   J. Bacteriol. 188:6966-6976(2006).
CC   -!- FUNCTION: Acts as a transcriptional regulator. Probably redox-
CC       responsive. The apo- but not holo-form probably binds DNA (By
CC       similarity). Affects the localization or efficiency of septum
CC       formation. Complemented by whiB2 of M.tuberculosis and whiB of
CC       S.coelicolor. {ECO:0000250, ECO:0000269|PubMed:10880571,
CC       ECO:0000269|PubMed:16980499}.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000250, ECO:0000305};
CC       Note=Binds 1 [4Fe-4S] cluster per subunit. Following nitrosylation of
CC       the [4Fe-4S] cluster binds 1 [4Fe-8(NO)] cluster per subunit.
CC       {ECO:0000250, ECO:0000305};
CC   -!- SUBUNIT: Oligomeric in native gel electrophoresis.
CC       {ECO:0000269|PubMed:16980499}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16946268}.
CC   -!- INDUCTION: In exponential phase (at protein level).
CC       {ECO:0000269|PubMed:16946268}.
CC   -!- PTM: The Fe-S cluster can be nitrosylated by nitric oxide (NO).
CC       {ECO:0000250}.
CC   -!- PTM: Upon Fe-S cluster removal intramolecular disulfide bonds are
CC       formed. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Essential. In depletion experiments, individual
CC       cells are elongated and/or filamented, with diminished septum formation
CC       and aberrant septal placement. The septa that do form may be immature
CC       as cytokinesis does not occur. Has no effect on FtsZ accumulation.
CC       Cells are less viable, colonies are smaller and the mutant is non-acid-
CC       fast under conditions of acetamide withdrawal.
CC       {ECO:0000269|PubMed:10880571, ECO:0000269|PubMed:16946268}.
CC   -!- MISCELLANEOUS: In this protein one of the ligands for the Fe-S cluster
CC       may be provided by Asp-71 rather than Cys-67.
CC   -!- SIMILARITY: Belongs to the WhiB family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF164439; AAD47079.1; -; Genomic_DNA.
DR   RefSeq; WP_003893222.1; NZ_SIUA01000021.1.
DR   AlphaFoldDB; Q9S426; -.
DR   SMR; Q9S426; -.
DR   OMA; CQGCEVR; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0035731; F:dinitrosyl-iron complex binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   HAMAP; MF_01479; WhiB; 1.
DR   InterPro; IPR034768; 4FE4S_WBL.
DR   InterPro; IPR003482; Whib.
DR   PANTHER; PTHR38839; PTHR38839; 1.
DR   Pfam; PF02467; Whib; 1.
DR   PROSITE; PS51674; 4FE4S_WBL; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Cytoplasm; Disulfide bond; DNA-binding; Iron; Iron-sulfur;
KW   Metal-binding; Transcription; Transcription regulation.
FT   CHAIN           1..129
FT                   /note="Transcriptional regulator WhiB2"
FT                   /id="PRO_0000420396"
FT   DOMAIN          66..123
FT                   /note="4Fe-4S Wbl-type"
FT   REGION          23..45
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         67
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000250"
FT   BINDING         90
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000305"
FT   BINDING         93
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000305"
FT   BINDING         99
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         67
FT                   /note="C->A: Not required to complement filamentous
FT                   phenotype in depletion experiments."
FT                   /evidence="ECO:0000269|PubMed:16980499"
FT   MUTAGEN         71
FT                   /note="D->A: Required to complement filamentous phenotype
FT                   in depletion experiments."
FT                   /evidence="ECO:0000269|PubMed:16980499"
FT   MUTAGEN         90
FT                   /note="C->A: Required to complement filamentous phenotype
FT                   in depletion experiments."
FT                   /evidence="ECO:0000269|PubMed:16980499"
FT   MUTAGEN         93
FT                   /note="C->A: Required to complement filamentous phenotype
FT                   in depletion experiments."
FT                   /evidence="ECO:0000269|PubMed:16980499"
FT   MUTAGEN         99
FT                   /note="C->A: Required to complement filamentous phenotype
FT                   in depletion experiments."
FT                   /evidence="ECO:0000269|PubMed:16980499"
FT   MUTAGEN         111
FT                   /note="G->P: Required to complement filamentous phenotype
FT                   in depletion experiments."
FT                   /evidence="ECO:0000269|PubMed:16980499"
FT   MUTAGEN         116
FT                   /note="L->P: Partial complementation of filamentous
FT                   phenotype in depletion experiments."
FT                   /evidence="ECO:0000269|PubMed:16980499"
SQ   SEQUENCE   129 AA;  14396 MW;  953A5C10E00CC16C CRC64;
     MSYESGDFDR VVRFDNRLLG SVSHAPHIDT GSTPTGAAGR PQLSLVPDSF DVAPEAEEDQ
     WQERALCAQT DPEAFFPEKG GSTREAKRIC QGCEVRDACL EYALAHDERF GIWGGLSERE
     RRRLKRGII
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024